Radcliffe Cardiology Launches New Title: JAPSC: Journal of Asian Pacific Society of Cardiology on Behalf of the Asian Pacific Society of Cardiology

April 16, 2021

Radcliffe Cardiology notes: The Asian Pacific Society of Cardiology and Radcliffe Cardiology is pleased to announce the launch of a new open access title, JAPSC: Journal of Asian Pacific Society of Cardiology.

Launching in 2021, JAPSC will be led by Dr. Yeo Khung Keong as Editor-in-Chief and will be the official journal of the Society. This exciting new journal will be a Gold Open Access journal publishing original research, reviews, expert opinion pieces, and case reports within cardiovascular disease and aims to provide a forum for cardiovascular research from across the Asia Pacific region.

Radcliffe Cardiology Launches New Title: Japsc: Journal Of Asian Pacific Society Of Cardiology On Behalf Of The Asian Pacific Society Of Cardiology

On behalf of the APSC, Dr. Yeo Khung Keong commented, “APSC is delighted to work with Radcliffe to launch the Journal of the Asian Pacific Society of Cardiology. We believe that the Asia Pacific has tremendous potential to generate new research and discoveries in the field of cardiovascular medicine and surgery. Given the great burden of cardiovascular disease across the region, the time is right for a cardiovascular journal that truly represents the needs of its people. We are incredibly excited by this opportunity and look forward to the contributions from our friends and colleagues in the Asia Pacific.”

The APSC President, Dr. Jack Tan Wei Chieh, added, “The APSC is excited about the inaugural launch of its dedicated Journal of the Asian Pacific Society of Cardiology, JAPSC. I would like to thank Dr. Wael Almahmeed (UAE) for kick-starting this initiative with a personal donation and the strong collaboration with Radcliffe to bring an Asian perspective to cardiovascular science, research, and education. We are also privileged to have Dr Yeo Khung Keong (Singapore) lead his editorial team members Dr. Junya Ako (Japan), Dr Derek Chew (Australia), and Dr. Kyung Woo Park (Korea) in spearheading JAPSC.”

Radcliffe Cardiology, David RamseyRadcliffe’s Chief Executive Officer & Co-founder, David Ramsey, commented, “We are delighted to be able to announce the launch of this title in partnership with the Asian Pacific Society of Cardiology, and we believe that this partnership will strengthen our commitment to facilitating the continuous medical education of specialist and general cardiologists and disseminating knowledge of the field to the wider cardiovascular community through open research.”

 

Professor Andrew CoatsRadcliffe’s Board Chairman, and world-renowned cardiologist, Professor Andrew Coats, himself an Asia-Pacific and EU linked researcher commented, “We at Radcliffe are all delighted to be working in partnership with the Asian Pacific Society of Cardiology, the leading international professional body in cardiovascular medicine in this increasingly important powerhouse region. We are proud of this new journal initiative and know this will strengthen our contribution to the professional medical education of physicians helping care for billions of people.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.